Skip to main content

Tirzepatide Injection Shortage

Last Updated: July 1, 2024
Status: Current

Products Affected - Description
    • Mounjaro subcutaneous solution for injection, Lilly USA, LLC, 10 mg/0.5 mL, pen injector, 4 count, NDC 00002-1471-80
    • Mounjaro subcutaneous solution for injection, Lilly USA, LLC, 15 mg/0.5 mL, pen injector, 4 count, NDC 00002-1457-80
    • Mounjaro subcutaneous solution for injection, Lilly USA, LLC, 7.5 mg/0.5 mL, pen injector, 4 count, NDC 00002-1484-80
    • Zepbound subcutaneous solution for injection, Lilly USA, LLC, 10 mg/0.5 mL, pen injector, 4 count, NDC 00002-2471-80
    • Zepbound subcutaneous solution for injection, Lilly USA, LLC, 15 mg/0.5 mL, pen injector, 4 count, NDC 00002-2457-80
    • Zepbound subcutaneous solution for injection, Lilly USA, LLC, 7.5 mg/0.5 mL, pen injector, 4 count, NDC 00002-2484-80
Reason for the Shortage
    • Lilly states the shortage is due to increased demand.
Available Products
    • Mounjaro subcutaneous solution for injection, Lilly USA, LLC, 12.5 mg/0.5 mL, pen injector, 4 count, NDC 00002-1460-80
    • Mounjaro subcutaneous solution for injection, Lilly USA, LLC, 2.5 mg/0.5 mL, pen injector, 4 count, NDC 00002-1506-80
    • Mounjaro subcutaneous solution for injection, Lilly USA, LLC, 5 mg/0.5 mL, pen injector, 4 count, NDC 00002-1495-80
    • Zepbound subcutaneous solution for injection, Lilly USA, LLC, 12.5 mg/0.5 mL, pen injector, 4 count, NDC 00002-2460-80
    • Zepbound subcutaneous solution for injection, Lilly USA, LLC, 2.5 mg/0.5 mL, pen injector, 4 count, NDC 00002-2506-80
    • Zepbound subcutaneous solution for injection, Lilly USA, LLC, 5 mg/0.5 mL, pen injector, 4 count, NDC 00002-2495-80

Estimated Resupply Dates

    • Lilly has Mounjaro 7.5 mg/0.5 mL, 10 mg/0.5 mL, and 15 mg/0.5 mL in limited supply.
    • Lilly also has Zepbound 7.5 mg/0.5 mL, 10 mg/0.5 mL, and 15 mg/0.5 mL in limited supply.

Updated

Updated July 1, 2024 by Leslie Jensen, PharmD, Drug Information Specialist. Created July 20, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer